IP Library Granted Patent US 7,579,026
Granted Patent B2
US 7,579,026 · App. 11/216,514 · Granted Aug 25, 2009

Methods for enhancing antioxidant enzyme activity and reducing c-reactive protein levels

Assignee: Lifeline Nutraceuticals Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,579,026
App. No.
11/216,514
Granted
Aug 25, 2009
Kind
B2
Abstract

An antioxidant-promoting composition that increases antioxidant defense potential in a subject is disclosed comprising Bacopa monniera extract; milk thistle extract, ashwagandha powder, green tea extract, Gotu kola powder, Ginko biloba leaf extract; Aloe vera powder; turmeric extract; and N-acetyl cysteine. The antioxidant-promoting composition of the invention safely induces cellular antioxidant potential to achieve an overall net decrease in oxidative stress without the undesirable side-effects associated with the individual components of the antioxidant-promoting composition. Also disclosed is a method for reducing the undesirable side-effects of free radicals in a subject by administering to a subject in need of such antioxidants an effective amount of antioxidant-promoting composition of the invention.

Claims (5)

1. A method of increasing antioxidant enzyme activity in a subject, said method comprising administering to a subject in need thereof an effective amount of a composition comprising: at least 150 milligrams Bacopa monniera extract having 45 percent bacosides or greater; at least 225 milligrams Silybum marianum (milk thistle) extract having between 70 percent and 80 percent silymarin; at least 150 mg Withania somnifera (ashwagandha) powder; at least 75 milligrams Camellia sinensis (green tea) extract having 98 percent polyphenols and 45 percent epigallocatechin gallate; and at least 75 milligrams turmeric extract having 95 percent curcumin, wherein the composition reduces plaque formation in the vasculature of the subject thereby reducing excessive atherosclerosis or hypertension.

2. The method of claim 1 , wherein the subject is administered from 650 mg/day to 1000 mg/day of the composition.

3. The method according to claim 1 , wherein the composition is administered daily as an oral dietary supplement.

4. The method of claim 2 , wherein the composition includes one or more excipients including: calcium carbonate; croscarmellose sodium; dicalcium phosphate; magnesium stearate; microcrystalline cellulose; modified cellulose; silica; and stearic acid.

5. A method of increasing antioxidant enzyme activity in a subject, said method comprising administering to a subject in need thereof an effective amount of a composition comprising: up to 500 milligrams Bacopa monniera extract having 45 percent bacosides or greater; up to 500 milligrams Silybum marianum (milk thistle) extract having between 70 percent and 80 percent silymarin; up to 500 mg Withania somnifera (ashwagandha) powder; up to 500 milligrams Camellia sinensis (green tea) extract having 98 percent polyphenols and 45 percent epigallocatechin gallate; and up to 500 milligrams turmeric extract having 95 percent curcumin, wherein the composition reduces plaque formation in the vasculature of the subject thereby reducing excessive atherosclerosis or hypertension.

Assignments (5)
SECURITY INTEREST Recorded Apr 12, 2024
From: LIFEVANTAGE CORPORATION
To: BANK OF AMERICA, N.A.
Reel/Frame 067093/0888 →
RELEASE OF SECURITY INTEREST Recorded Mar 30, 2016
From: TCW SPECIAL SITUATIONS, LLC
To: LIFELINE NUTRACEUTICALS CORPORATION,
Reel/Frame 038141/0346 →
SECURITY AGREEMENT Recorded Dec 24, 2013
From: LIFELINE NUTRACEUTICALS CORPORATION
To: TCW SPECIAL SITUATIONS, LLC, AS COLLATERAL AGENT
Reel/Frame 031869/0158 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2007
From: MYHILL, PAUL R.; DRISCOLL, WILLIAM J.
To: LIFELINE NUTRACEUTICALS CORPORATION
Reel/Frame 019563/0908 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2007
From: DRISCOLL, WILLIAM J.; MYHILL, PAUL R.
To: LIFELINE NUTRACEUTICALS CORPORATION
Reel/Frame 019563/0916 →
Continuity (9)
Continuation In Part 1108832300 · Mar 23, 2005
Provisional Application 6055580200 · Mar 23, 2004
Provisional Application 6059052800 · Jul 23, 2004
Provisional Application 6060463800 · Aug 26, 2004
Provisional Application 6060764800 · Sep 7, 2004
Provisional Application 6061074900 · Sep 17, 2004
Provisional Application 6064375400 · Jan 13, 2005
Provisional Application 6064670700 · Jan 25, 2005
Related Publication 20060008544A1 · Jan 12, 2006